Literature DB >> 19587281

Phosphorylation of prion protein at serine 43 induces prion protein conformational change.

Paresa N Giannopoulos1, Catherine Robertson, Julie Jodoin, Hemant Paudel, Stephanie A Booth, Andrea C LeBlanc.   

Abstract

The cause of the conformational change of normal cellular prion protein (PrP) into its disease-associated form is unknown. Posttranslational modifications, such as glycosylation, acetylation, S-nitrosylation, and phosphorylation, are known to induce protein conformational changes. Here, we investigated whether phosphorylation could induce the conformational change of PrP because PrP contains several kinase motifs and has been found recently in the cytosol, in which kinases generally reside. Neuronal cyclin-dependent kinase 5 (Cdk5) phosphorylated recombinant PrP(23-231) at serine 43 (S43) in an in vitro kinase assay. Cdk5-phosphorylated PrP became proteinase K resistant, formed Congo Red-positive fibrils, and formed aggregates that were immunostained with anti-PrP and anti-phospho-PrP(S43) (anti-pPrP(S43)). pPrP(S43) was detected in PrP/Cdk5/p25 cotransfected N2a cells. Roscovitine inhibition of Cdk5 activity or transfection of N2a cells with mutant PrP S43A eliminated the anti-pPrP(S43)-immunopositive protein. Alkaline phosphatase-sensitive and proteinase K-resistant pPrP(S43) immunoreactivity was observed in scrapie-infected but not control-injected mice brains. These results raise the possibility that phosphorylation could represent a physiological mechanism of PrP conversion in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19587281      PMCID: PMC2745063          DOI: 10.1523/JNEUROSCI.2294-09.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  RNA molecules stimulate prion protein conversion.

Authors:  Nathan R Deleault; Ralf W Lucassen; Surachai Supattapone
Journal:  Nature       Date:  2003-10-16       Impact factor: 49.962

2.  Characterization of scrapie infection in mouse neuroblastoma cells.

Authors:  R E Race; L H Fadness; B Chesebro
Journal:  J Gen Virol       Date:  1987-05       Impact factor: 3.891

3.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins.

Authors:  R J Kascsak; R Rubenstein; P A Merz; M Tonna-DeMasi; R Fersko; R I Carp; H M Wisniewski; H Diringer
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

4.  Neurotoxicity and neurodegeneration when PrP accumulates in the cytosol.

Authors:  Jiyan Ma; Robert Wollmann; Susan Lindquist
Journal:  Science       Date:  2002-10-17       Impact factor: 47.728

5.  Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons.

Authors:  Xavier Roucou; Qi Guo; Yan Zhang; Cynthia G Goodyer; Andrea C LeBlanc
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

6.  Synthetic mammalian prions.

Authors:  Giuseppe Legname; Ilia V Baskakov; Hoang-Oanh B Nguyen; Detlev Riesner; Fred E Cohen; Stephen J DeArmond; Stanley B Prusiner
Journal:  Science       Date:  2004-07-30       Impact factor: 47.728

Review 7.  Prion protein conversion in vitro.

Authors:  Surachai Supattapone
Journal:  J Mol Med (Berl)       Date:  2004-03-10       Impact factor: 4.599

Review 8.  Mammalian prion biology: one century of evolving concepts.

Authors:  Adriano Aguzzi; Magdalini Polymenidou
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

9.  Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells.

Authors:  Sabine Gilch; Franziska Wopfner; Ingrid Renner-Müller; Elisabeth Kremmer; Christine Bauer; Eckhard Wolf; Gottfried Brem; Martin H Groschup; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2003-03-11       Impact factor: 5.157

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  6 in total

1.  Baking a mass-spectrometry data PIE with McMC and simulated annealing: predicting protein post-translational modifications from integrated top-down and bottom-up data.

Authors:  Stuart R Jefferys; Morgan C Giddings
Journal:  Bioinformatics       Date:  2011-03-15       Impact factor: 6.937

2.  Cyclin-dependent kinase 5 phosphorylation of familial prion protein mutants exacerbates conversion into amyloid structure.

Authors:  Raphaël Rouget; Gyanesh Sharma; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2015-01-08       Impact factor: 5.157

3.  Effects of peptidyl-prolyl isomerase 1 depletion in animal models of prion diseases.

Authors:  Giuseppe Legname; Tommaso Virgilio; Edoardo Bistaffa; Chiara Maria Giulia De Luca; Marcella Catania; Paola Zago; Elisa Isopi; Ilaria Campagnani; Fabrizio Tagliavini; Giorgio Giaccone; Fabio Moda
Journal:  Prion       Date:  2018-05-18       Impact factor: 3.931

Review 4.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

5.  The N-terminal sequence of prion protein consists an epitope specific to the abnormal isoform of prion protein (PrP(Sc)).

Authors:  Kentaro Masujin; Yuko Kaku-Ushiki; Ritsuko Miwa; Hiroyuki Okada; Yoshihisa Shimizu; Kazuo Kasai; Yuichi Matsuura; Takashi Yokoyama
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 6.  Do Post-Translational Modifications Influence Protein Aggregation in Neurodegenerative Diseases: A Systematic Review.

Authors:  Larissa-Nele Schaffert; Wayne G Carter
Journal:  Brain Sci       Date:  2020-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.